Radiopharm Theranostics RADX
NASDAQ RADX
$1.42 -0.06 (-4.05%)
At close: Oct 2, 2026 · 4:00 PM EDT

Radiopharm Theranostics (RADX) Net Income towards Common Stockholders (2023 - 2026)

Updated

Radiopharm Theranostics' Net Income towards Common Stockholders was -$386,785 in FY2026 (year ended Jun 30, 2026), compared with -$38.34 million in FY2025.

Analysis

Radiopharm Theranostics (RADX) Net Income towards Common Stockholders (2023 - 2026) Analysis & Trends

From FY2023 onward, Radiopharm Theranostics has reported Net Income towards Common Stockholders for 4 fiscal years.

  • Annual Net Income towards Common Stockholders has moved between -$38.34 million (FY2025) and -$315,996 (FY2024) over five years.
  • Per Business Quant data, Net Income towards Common Stockholders in earlier fiscal years was -$38.34 million in FY2025, -$315,996 in FY2024 and -$34.61 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 5.53 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.61 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.89 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.50 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -248.00 Mn
10 Radiopharm Theranostics 5.03 Bn 5.00 Bn 186,835.86 -40.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -40.40 Mn
Jun 30, 2025 -38.34 Mn
Jun 30, 2024 -47.95 Mn
Jun 30, 2023 -34.61 Mn
API Access

Radiopharm Theranostics Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=RADX&period=max&api_key=YOUR_API_KEY